Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study of ABR-215050 to Treat Prostate Cancer
This study is ongoing, but not recruiting participants.
Study NCT00560482   Information provided by Active Biotech AB

First Received on November 15, 2007.   Last Updated on December 22, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
ABR-215050, tasquinimod
Placebo
Sponsors listed in this trial
Active Biotech AB


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services